Peeyush N. Goel

785 total citations
24 papers, 622 citations indexed

About

Peeyush N. Goel is a scholar working on Molecular Biology, Biomaterials and Oncology. According to data from OpenAlex, Peeyush N. Goel has authored 24 papers receiving a total of 622 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 11 papers in Biomaterials and 7 papers in Oncology. Recurrent topics in Peeyush N. Goel's work include Nanoparticle-Based Drug Delivery (10 papers), HER2/EGFR in Cancer Research (4 papers) and RNA Interference and Gene Delivery (3 papers). Peeyush N. Goel is often cited by papers focused on Nanoparticle-Based Drug Delivery (10 papers), HER2/EGFR in Cancer Research (4 papers) and RNA Interference and Gene Delivery (3 papers). Peeyush N. Goel collaborates with scholars based in India, United States and Switzerland. Peeyush N. Goel's co-authors include Rajiv P. Gude, Mark I. Greene, Rajani Athawale, Darshana Jain, Amrita Bajaj, Sanket Shah, Ankitkumar S. Jain, Mangal S. Nagarsenker, Satish Patil and Arehalli S. Manjappa and has published in prestigious journals such as The FASEB Journal, Biochemical and Biophysical Research Communications and Frontiers in Immunology.

In The Last Decade

Peeyush N. Goel

24 papers receiving 615 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peeyush N. Goel India 14 258 226 128 98 97 24 622
Maryam A. Shetab Boushehri Germany 13 238 0.9× 142 0.6× 125 1.0× 122 1.2× 95 1.0× 24 583
Hasan Akbaba Türkiye 11 222 0.9× 170 0.8× 157 1.2× 106 1.1× 74 0.8× 34 556
Kentaro Hatanaka Japan 13 325 1.3× 277 1.2× 130 1.0× 65 0.7× 83 0.9× 20 588
Shweta Sharma United States 9 259 1.0× 215 1.0× 179 1.4× 53 0.5× 54 0.6× 11 491
Patrick J. Kennedy Portugal 15 361 1.4× 147 0.7× 125 1.0× 81 0.8× 57 0.6× 21 706
Yudong Song China 9 273 1.1× 160 0.7× 178 1.4× 143 1.5× 43 0.4× 11 531
Xiumei Zhu China 13 240 0.9× 169 0.7× 97 0.8× 64 0.7× 34 0.4× 20 525
Fazhan Wang China 16 320 1.2× 103 0.5× 78 0.6× 104 1.1× 88 0.9× 31 613
Shuangshuang Song China 15 209 0.8× 135 0.6× 88 0.7× 45 0.5× 125 1.3× 36 634
Chantal C.M. Appeldoorn Netherlands 16 550 2.1× 339 1.5× 146 1.1× 91 0.9× 126 1.3× 22 976

Countries citing papers authored by Peeyush N. Goel

Since Specialization
Citations

This map shows the geographic impact of Peeyush N. Goel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peeyush N. Goel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peeyush N. Goel more than expected).

Fields of papers citing papers by Peeyush N. Goel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peeyush N. Goel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peeyush N. Goel. The network helps show where Peeyush N. Goel may publish in the future.

Co-authorship network of co-authors of Peeyush N. Goel

This figure shows the co-authorship network connecting the top 25 collaborators of Peeyush N. Goel. A scholar is included among the top collaborators of Peeyush N. Goel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peeyush N. Goel. Peeyush N. Goel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Goel, Peeyush N., et al.. (2023). Dual kinase inhibitor for EGFR mutants and ErbB2 limit breast cancer. Biochemical and Biophysical Research Communications. 651. 39–46. 4 indexed citations
2.
Goel, Peeyush N., et al.. (2021). Regulatory T Cells: Regulation of Identity and Function. Frontiers in Immunology. 12. 750542–750542. 114 indexed citations
3.
4.
Lengfeld, Justin, Hongtao Zhang, S.P. Stoesz, et al.. (2021). Challenges in Detection of Serum Oncoprotein: Relevance to Breast Cancer Diagnostics. Breast Cancer Targets and Therapy. Volume 13. 575–593. 8 indexed citations
5.
Goel, Peeyush N., et al.. (2020). PRMT5 and Tip60 Modify FOXP3 Function in Tumor Immunity. Critical Reviews in Immunology. 40(4). 283–295. 10 indexed citations
6.
Goel, Peeyush N., et al.. (2019). Notch signaling inhibition protects against LPS mediated osteolysis. Biochemical and Biophysical Research Communications. 515(4). 538–543. 8 indexed citations
7.
Goel, Peeyush N., et al.. (2019). Suppression of Notch Signaling in Osteoclasts Improves Bone Regeneration and Healing. Journal of Orthopaedic Research®. 37(10). 2089–2103. 16 indexed citations
8.
Jain, Darshana, Rajani Athawale, Amrita Bajaj, et al.. (2015). Evaluation of anti-metastatic potential of Cisplatin polymeric nanocarriers on B16F10 melanoma cells. Saudi Pharmaceutical Journal. 23(4). 341–351. 14 indexed citations
9.
Jain, Ankitkumar S., Peeyush N. Goel, Sanket Shah, et al.. (2014). Docetaxel in cationic lipid nanocapsules for enhancedin vivoactivity. Pharmaceutical Development and Technology. 21(1). 76–85. 6 indexed citations
10.
Manjappa, Arehalli S., Peeyush N. Goel, Rajiv P. Gude, & R. S. R. Murthy. (2014). Anti-neuropilin 1 antibody Fab′ fragment conjugated liposomal docetaxel for active targeting of tumours. Journal of drug targeting. 22(8). 698–711. 19 indexed citations
11.
Shah, Sanket, Peeyush N. Goel, Ankitkumar S. Jain, et al.. (2014). Liposomes for targeting hepatocellular carcinoma: Use of conjugated arabinogalactan as targeting ligand. International Journal of Pharmaceutics. 477(1-2). 128–139. 44 indexed citations
12.
Jain, Ankitkumar S., Peeyush N. Goel, Sanket Shah, et al.. (2014). Tamoxifen guided liposomes for targeting encapsulated anticancer agent to estrogen receptor positive breast cancer cells: In vitro and in vivo evaluation. Biomedicine & Pharmacotherapy. 68(4). 429–438. 38 indexed citations
13.
Jain, Darshana, et al.. (2014). Unraveling the cytotoxic potential of Temozolomide loaded into PLGA nanoparticles. DARU Journal of Pharmaceutical Sciences. 22(1). 18–18. 37 indexed citations
14.
Jain, Darshana, Amrita Bajaj, Rajani Athawale, et al.. (2014). Surface-coated PLA nanoparticles loaded with temozolomide for improved brain deposition and potential treatment of gliomas: development, characterization andin vivostudies. Drug Delivery. 23(3). 989–1006. 36 indexed citations
15.
Goel, Peeyush N., et al.. (2014). Investigating the effects of Pentoxifylline on human breast cancer cells using Raman spectroscopy. Journal of Innovative Optical Health Sciences. 8(2). 1550004–1550004. 12 indexed citations
16.
Manjappa, Arehalli S., et al.. (2013). Is an Alternative Drug Delivery System Needed for Docetaxel? The Role of Controlling Epimerization in Formulations and Beyond. Pharmaceutical Research. 30(10). 2675–2693. 22 indexed citations
17.
Goel, Peeyush N. & Rajiv P. Gude. (2013). Delineating the anti-metastatic potential of pentoxifylline in combination with liposomal doxorubicin against breast cancer cells. Biomedicine & Pharmacotherapy. 68(2). 191–200. 13 indexed citations
18.
Goel, Peeyush N. & Rajiv P. Gude. (2013). Pentoxifylline regulates the cellular adhesion and its allied receptors to extracellular matrix components in breast cancer cells. Biomedicine & Pharmacotherapy. 68(1). 93–99. 12 indexed citations
19.
Jain, Darshana, et al.. (2013). Studies on stabilization mechanism and stealth effect of poloxamer 188 onto PLGA nanoparticles. Colloids and Surfaces B Biointerfaces. 109. 59–67. 72 indexed citations
20.
Goel, Peeyush N., et al.. (2011). Unravelling the antimetastatic potential of pentoxifylline, a methylxanthine derivative in human MDA-MB-231 breast cancer cells. Molecular and Cellular Biochemistry. 358(1-2). 141–151. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maryam A. Shetab Boushehri Breakdown of academic impact, for papers by Hasan Akbaba Breakdown of academic impact, for papers by Kentaro Hatanaka Breakdown of academic impact, for papers by Shweta Sharma Breakdown of academic impact, for papers by Patrick J. Kennedy Breakdown of academic impact, for papers by Yudong Song Breakdown of academic impact, for papers by Xiumei Zhu Breakdown of academic impact, for papers by Fazhan Wang Breakdown of academic impact, for papers by Shuangshuang Song Breakdown of academic impact, for papers by Chantal C.M. Appeldoorn
Rankless by CCL
2026